List of Tables
Table 1. Global Anti-amyloid Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-amyloid Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-amyloid Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-amyloid Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-amyloid Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-amyloid Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-amyloid Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-amyloid Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-amyloid Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-amyloid Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-amyloid Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-amyloid Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-amyloid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-amyloid Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-amyloid Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-amyloid Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-amyloid Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti-amyloid Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-amyloid Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti-amyloid Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-amyloid Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-amyloid Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-amyloid Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-amyloid Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-amyloid Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-amyloid Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-amyloid Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-amyloid Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-amyloid Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-amyloid Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-amyloid Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-amyloid Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-amyloid Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-amyloid Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-amyloid Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-amyloid Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-amyloid Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-amyloid Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-amyloid Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-amyloid Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-amyloid Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-amyloid Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-amyloid Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Anti-amyloid Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Anti-amyloid Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Anti-amyloid Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Anti-amyloid Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Anti-amyloid Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-amyloid Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-amyloid Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-amyloid Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti-amyloid Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti-amyloid Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-amyloid Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-amyloid Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-amyloid Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-amyloid Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-amyloid Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-amyloid Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-amyloid Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-amyloid Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti-amyloid Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti-amyloid Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-amyloid Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-amyloid Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-amyloid Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-amyloid Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-amyloid Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Eisai Company Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Anti-amyloid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Eisai Anti-amyloid Drugs Product
Table 74. Eisai Recent Developments/Updates
Table 75. Biogen Company Information
Table 76. Biogen Description and Business Overview
Table 77. Biogen Anti-amyloid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Biogen Anti-amyloid Drugs Product
Table 79. Biogen Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Anti-amyloid Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Anti-amyloid Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Anti-amyloid Drugs Distributors List
Table 88. Anti-amyloid Drugs Customers List
Table 89. Anti-amyloid Drugs Market Trends
Table 90. Anti-amyloid Drugs Market Drivers
Table 91. Anti-amyloid Drugs Market Challenges
Table 92. Anti-amyloid Drugs Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-amyloid Drugs
Figure 2. Global Anti-amyloid Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-amyloid Drugs Market Share by Type: 2023 & 2030
Figure 4. Lecanemab Product Picture
Figure 5. Donanemab Product Picture
Figure 6. Global Anti-amyloid Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-amyloid Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Anti-amyloid Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-amyloid Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti-amyloid Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Anti-amyloid Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Anti-amyloid Drugs Report Years Considered
Figure 16. Anti-amyloid Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Anti-amyloid Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Anti-amyloid Drugs Players: Market Share by Revenue in Anti-amyloid Drugs in 2023
Figure 19. Anti-amyloid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Anti-amyloid Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti-amyloid Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Anti-amyloid Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti-amyloid Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti-amyloid Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-amyloid Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti-amyloid Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Anti-amyloid Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Anti-amyloid Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Anti-amyloid Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Anti-amyloid Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Anti-amyloid Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Anti-amyloid Drugs by Type (2019-2030)
Figure 53. Global Anti-amyloid Drugs Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Anti-amyloid Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Anti-amyloid Drugs by Application (2019-2030)
Figure 56. Global Anti-amyloid Drugs Price (US$/Unit) by Application (2019-2030)
Figure 57. Anti-amyloid Drugs Value Chain
Figure 58. Anti-amyloid Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
